Eliel Bayever MD MRCP
Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Chief Medical Officer, Elucida Oncology, Inc.
Join to View Full Profile
Elucida Oncology, Inc.1 Deer Park Drive, Suite EMonmouth Junction, NJ 08852
Dr. Bayever is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of the WitwatersrandClass of 1973
Certifications & Licensure
CA State Medical License 1992 - 2019
Clinical Trials
Publications & Presentations
PubMed
- 747 citationsNanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, ...Andrea Wang-Gillam, Chung-Pin Li, György Bodoky, Andrew Dean, Yan Shen Shan
Lancet. 2016-02-06 - A Systematic Literature Review To Identify And Compare Clinical Trials Evaluating Novel Therapeutic Agents In Post-Gemcitabine Advanced Pancreatic CancerDF Gaddy, C Becker, H Li, R Bennett, Y Yang
Value in Health. 2015-11-01 - 65 citationsThe status of hematopoietic stem cell transplantation in lysosomal storage diseaseJ. Jeffrey Malatack, Deborah Consolini, Eliel Bayever
Pediatric Neurology. 2003-11-01
Press Mentions
- Quest Announces That OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead Investigational Drug, Oregovomab, in Frontline Ovarian Cancer and Appoints Dr. Sunil Gupta as Chief Medical OfficerNovember 9th, 2020
Elucida Oncology Appoints Dr. Eliel Bayever as Chief Medical OfficerOctober 1st, 2020
OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian CancerFebruary 15th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
